Cargando…

The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia

BACKGROUND: A significant proportion of cancer patients use complementary and alternative medicine (CAM) along with conventional therapies (CT), whereas a smaller proportion delay or defer CT in favor of CAM. Previous studies exploring CAM use among cancer patients in the Middle East region have sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuelgasim, Khadega A., Alsharhan, Yousef, Alenzi, Tariq, Alhazzani, Abdulaziz, Ali, Yosra Z., Jazieh, Abdul Rahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848536/
https://www.ncbi.nlm.nih.gov/pubmed/29530034
http://dx.doi.org/10.1186/s12906-018-2150-8
_version_ 1783305888419807232
author Abuelgasim, Khadega A.
Alsharhan, Yousef
Alenzi, Tariq
Alhazzani, Abdulaziz
Ali, Yosra Z.
Jazieh, Abdul Rahman
author_facet Abuelgasim, Khadega A.
Alsharhan, Yousef
Alenzi, Tariq
Alhazzani, Abdulaziz
Ali, Yosra Z.
Jazieh, Abdul Rahman
author_sort Abuelgasim, Khadega A.
collection PubMed
description BACKGROUND: A significant proportion of cancer patients use complementary and alternative medicine (CAM) along with conventional therapies (CT), whereas a smaller proportion delay or defer CT in favor of CAM. Previous studies exploring CAM use among cancer patients in the Middle East region have shown discrepant results. This study investigates the prevalence and pattern of CAM use by Saudi cancer patients. It also discusses the possible benefits and harm related to CAM use by cancer patients, and it explores the beliefs patients hold and their transparency with health care providers regarding their CAM use. METHODS: A cross-sectional study was conducted in oncology wards and outpatient clinics by using face-to-face interviews with the participants. RESULTS: A total of 156 patients with a median age of 50 years (18–84) participated in the study. The prevalence of CAM use was 69.9%; the most prominent types of CAM were those of a religious nature, such as supplication (95.4%), Quran recitation (88.1%), consuming Zamzam water (84.4%), and water upon which the Quran has been read (63.3%). Drinking camel milk was reported by 24.1% of CAM users, whereas camel urine was consumed by 15.7%. A variety of reasons were given for CAM use: 75% reported that they were using CAM to treat cancer, enhance mood (18.3%),control pain (11.9%), enhance the immune system (11%),increase physical fitness (6.4%), and improve appetite (4.6%). Thirty percent of CAM users had discussed the issue with their doctors; only 7.7% had done so with their nurses. CONCLUSIONS: The use of CAM, including camel products, is highly prevalent among cancer patients in the Middle East, but these patients do not necessarily divulge their CAM use to their treating physicians and nurses. Although CAM use can be beneficial, some can be very harmful, especially for cancer patients. Association is known between camel products and brucellosis and Middle East respiratory syndrome coronavirus (MERS-CoV). Both can lead to tremendous morbidity in immune-compromised patients. Doctor–patient communication regarding CAM use is of paramount importance in cancer care. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12906-018-2150-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5848536
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58485362018-03-21 The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia Abuelgasim, Khadega A. Alsharhan, Yousef Alenzi, Tariq Alhazzani, Abdulaziz Ali, Yosra Z. Jazieh, Abdul Rahman BMC Complement Altern Med Research Article BACKGROUND: A significant proportion of cancer patients use complementary and alternative medicine (CAM) along with conventional therapies (CT), whereas a smaller proportion delay or defer CT in favor of CAM. Previous studies exploring CAM use among cancer patients in the Middle East region have shown discrepant results. This study investigates the prevalence and pattern of CAM use by Saudi cancer patients. It also discusses the possible benefits and harm related to CAM use by cancer patients, and it explores the beliefs patients hold and their transparency with health care providers regarding their CAM use. METHODS: A cross-sectional study was conducted in oncology wards and outpatient clinics by using face-to-face interviews with the participants. RESULTS: A total of 156 patients with a median age of 50 years (18–84) participated in the study. The prevalence of CAM use was 69.9%; the most prominent types of CAM were those of a religious nature, such as supplication (95.4%), Quran recitation (88.1%), consuming Zamzam water (84.4%), and water upon which the Quran has been read (63.3%). Drinking camel milk was reported by 24.1% of CAM users, whereas camel urine was consumed by 15.7%. A variety of reasons were given for CAM use: 75% reported that they were using CAM to treat cancer, enhance mood (18.3%),control pain (11.9%), enhance the immune system (11%),increase physical fitness (6.4%), and improve appetite (4.6%). Thirty percent of CAM users had discussed the issue with their doctors; only 7.7% had done so with their nurses. CONCLUSIONS: The use of CAM, including camel products, is highly prevalent among cancer patients in the Middle East, but these patients do not necessarily divulge their CAM use to their treating physicians and nurses. Although CAM use can be beneficial, some can be very harmful, especially for cancer patients. Association is known between camel products and brucellosis and Middle East respiratory syndrome coronavirus (MERS-CoV). Both can lead to tremendous morbidity in immune-compromised patients. Doctor–patient communication regarding CAM use is of paramount importance in cancer care. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12906-018-2150-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-12 /pmc/articles/PMC5848536/ /pubmed/29530034 http://dx.doi.org/10.1186/s12906-018-2150-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Abuelgasim, Khadega A.
Alsharhan, Yousef
Alenzi, Tariq
Alhazzani, Abdulaziz
Ali, Yosra Z.
Jazieh, Abdul Rahman
The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia
title The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia
title_full The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia
title_fullStr The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia
title_full_unstemmed The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia
title_short The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia
title_sort use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in saudi arabia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848536/
https://www.ncbi.nlm.nih.gov/pubmed/29530034
http://dx.doi.org/10.1186/s12906-018-2150-8
work_keys_str_mv AT abuelgasimkhadegaa theuseofcomplementaryandalternativemedicinebypatientswithcanceracrosssectionalsurveyinsaudiarabia
AT alsharhanyousef theuseofcomplementaryandalternativemedicinebypatientswithcanceracrosssectionalsurveyinsaudiarabia
AT alenzitariq theuseofcomplementaryandalternativemedicinebypatientswithcanceracrosssectionalsurveyinsaudiarabia
AT alhazzaniabdulaziz theuseofcomplementaryandalternativemedicinebypatientswithcanceracrosssectionalsurveyinsaudiarabia
AT aliyosraz theuseofcomplementaryandalternativemedicinebypatientswithcanceracrosssectionalsurveyinsaudiarabia
AT jaziehabdulrahman theuseofcomplementaryandalternativemedicinebypatientswithcanceracrosssectionalsurveyinsaudiarabia
AT abuelgasimkhadegaa useofcomplementaryandalternativemedicinebypatientswithcanceracrosssectionalsurveyinsaudiarabia
AT alsharhanyousef useofcomplementaryandalternativemedicinebypatientswithcanceracrosssectionalsurveyinsaudiarabia
AT alenzitariq useofcomplementaryandalternativemedicinebypatientswithcanceracrosssectionalsurveyinsaudiarabia
AT alhazzaniabdulaziz useofcomplementaryandalternativemedicinebypatientswithcanceracrosssectionalsurveyinsaudiarabia
AT aliyosraz useofcomplementaryandalternativemedicinebypatientswithcanceracrosssectionalsurveyinsaudiarabia
AT jaziehabdulrahman useofcomplementaryandalternativemedicinebypatientswithcanceracrosssectionalsurveyinsaudiarabia